| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bc1962468e69e120b50aee584c365f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67aefcd72a8486568240e8931cc709b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4e9b7ebcdaf70da6c6ef31c5e23afa5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0262 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1492 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B8-00 |
| filingDate |
2007-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8e1983160062db1c6909aeaecdadf66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_006bd4287443d1cd040253d2239d90cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34f93bc3126ac7026ad433c3ac8c9f1f |
| publicationDate |
2008-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008228079-A1 |
| titleOfInvention |
Clinical utilization of contrast agents to define specific areas within the myocardial wall to provide guidance and localization for ablation, cyroablation, or other techniques in patients with post myocardial infarction |
| abstract |
Certain embodiments of the present invention provide systems and methods for ablating non-viable cardiac tissue. In an embodiment, the method may include locating non-viable cardiac tissue utilizing an electronic medical image. The method may also include locating non-viable cardiac tissue utilizing an ultrasound unit, wherein a contrast agent is used to characterize the non-viable cardiac tissue. The method may also include guiding a catheter to the location of the non-viable cardiac tissue according to the imaging of the ultrasound unit. The method may also include ablating the non-viable cardiac tissue. The ablating of the non-viable cardiac tissue may include cauterizing the non-viable cardiac tissue, cyroablating the non-viable cardiac tissue, or include radiofrequency ablation. The method may also include attempting to locate the non-viable cardiac tissue utilizing an electronic medical image after ablating the non-viable cardiac tissue. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10716462-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11457817-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10682179-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10736512-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10076238-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10143517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11559192-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11559352-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10722301-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10779904-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596472-B2 |
| priorityDate |
2007-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |